CA2064039C - Treatment to reduce edema for brain and musculature injuries - Google Patents
Treatment to reduce edema for brain and musculature injuries Download PDFInfo
- Publication number
- CA2064039C CA2064039C CA002064039A CA2064039A CA2064039C CA 2064039 C CA2064039 C CA 2064039C CA 002064039 A CA002064039 A CA 002064039A CA 2064039 A CA2064039 A CA 2064039A CA 2064039 C CA2064039 C CA 2064039C
- Authority
- CA
- Canada
- Prior art keywords
- brain
- musculature
- patient
- edema
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US386,885 | 1989-07-28 | ||
US07/386,885 US5137871A (en) | 1989-07-28 | 1989-07-28 | Treatment to reduce edema for brain and musculature injuries |
PCT/US1990/003003 WO1991001997A1 (en) | 1989-07-28 | 1990-05-30 | Treatment to reduce edema for brain and musculature injuries |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2064039A1 CA2064039A1 (en) | 1991-01-29 |
CA2064039C true CA2064039C (en) | 2001-01-02 |
Family
ID=23527476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002064039A Expired - Lifetime CA2064039C (en) | 1989-07-28 | 1990-05-30 | Treatment to reduce edema for brain and musculature injuries |
Country Status (11)
Country | Link |
---|---|
US (2) | US5137871A (es) |
EP (1) | EP0484340B1 (es) |
JP (1) | JP3012319B2 (es) |
AT (1) | ATE131064T1 (es) |
AU (1) | AU641166B2 (es) |
CA (1) | CA2064039C (es) |
DE (1) | DE69024053T2 (es) |
DK (1) | DK0484340T3 (es) |
ES (1) | ES2081989T3 (es) |
IE (1) | IE63053B1 (es) |
WO (1) | WO1991001997A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5488033A (en) * | 1989-07-28 | 1996-01-30 | The Regents Of The University Of California | Treatment to reduce edema |
US5137871A (en) * | 1989-07-28 | 1992-08-11 | Regents Of The University Of California | Treatment to reduce edema for brain and musculature injuries |
US5374621A (en) * | 1991-09-13 | 1994-12-20 | Regents Of The University Of California | Neurotensin method for inhibiting vascular leakage |
EP0781140A4 (en) * | 1994-09-12 | 1999-11-03 | Univ Pennsylvania | FACTOR INHIBITING THE CORTICOTROPIN RELEASE AND METHOD FOR ITS USE |
US6039956A (en) * | 1994-09-12 | 2000-03-21 | Pennsylvania, Trustees Of The University Of, The | Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder |
US5869450A (en) * | 1996-03-06 | 1999-02-09 | The Regents Of The University Of California | Anti-inflammatory compositions and method with corticotropin-releasing factor analogs |
US6011066A (en) * | 1998-02-02 | 2000-01-04 | Veterans General Hospital-Taipei | Method for treating septic shock |
WO2000037502A2 (en) * | 1998-12-22 | 2000-06-29 | Genentech, Inc. | Vascular endothelial cell growth factor antagonists and uses thereof |
US6849600B2 (en) * | 2002-03-25 | 2005-02-01 | The Regents Of The University Of California, Berkeley | Corticotropin-releasing hormone analogs |
WO2006021814A2 (en) * | 2004-07-08 | 2006-03-02 | Aimsco Limited | Medicament |
GB0415359D0 (en) * | 2004-07-08 | 2004-08-11 | Aimsco Ltd | Medicament |
GB0600202D0 (en) * | 2006-01-06 | 2006-02-15 | Aimsco Ltd | Treatment of HIV |
US7455447B2 (en) * | 2006-05-19 | 2008-11-25 | Mediatek Inc. | Method and apparatus for a portable device |
WO2010033207A1 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
WO2013169939A2 (en) | 2012-05-08 | 2013-11-14 | Aeromics, Llc | New methods |
WO2015069961A1 (en) | 2013-11-06 | 2015-05-14 | Aeromics, Llc | Novel prodrug salts |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3980778A (en) * | 1973-10-25 | 1976-09-14 | The Upjohn Company | Anti-inflammatory steroid |
US4579844A (en) * | 1976-05-13 | 1986-04-01 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
US4404198A (en) * | 1979-01-24 | 1983-09-13 | Beecham Inc. | Phenyl Salicylate as a topical anti-inflammatory |
US4415558A (en) * | 1981-06-08 | 1983-11-15 | The Salk Institute For Biological Studies | CRF And analogs |
US4517181A (en) * | 1982-09-15 | 1985-05-14 | The Salk Institute For Biological Studies | Mammalian PGRF |
EP0120000A1 (en) * | 1982-09-29 | 1984-10-03 | LEDERIS, Karl P. | Urotensin peptides |
US4528189A (en) * | 1983-02-03 | 1985-07-09 | The Salk Institute For Biological Studies | Urotensin peptides |
US4489163A (en) * | 1983-04-14 | 1984-12-18 | The Salk Institute For Biological Studies | rCRF and analogs |
US4605642A (en) * | 1984-02-23 | 1986-08-12 | The Salk Institute For Biological Studies | CRF antagonists |
US4594329A (en) * | 1984-05-14 | 1986-06-10 | The Salk Institute For Biological Studies | CRF analogs |
US4801612A (en) * | 1986-07-03 | 1989-01-31 | Regents Of The University Of California | Method of inhibiting inflammatory response |
US5137871A (en) * | 1989-07-28 | 1992-08-11 | Regents Of The University Of California | Treatment to reduce edema for brain and musculature injuries |
-
1989
- 1989-07-28 US US07/386,885 patent/US5137871A/en not_active Expired - Lifetime
-
1990
- 1990-05-30 AT AT90909011T patent/ATE131064T1/de not_active IP Right Cessation
- 1990-05-30 WO PCT/US1990/003003 patent/WO1991001997A1/en active IP Right Grant
- 1990-05-30 EP EP90909011A patent/EP0484340B1/en not_active Expired - Lifetime
- 1990-05-30 DE DE69024053T patent/DE69024053T2/de not_active Expired - Lifetime
- 1990-05-30 CA CA002064039A patent/CA2064039C/en not_active Expired - Lifetime
- 1990-05-30 ES ES90909011T patent/ES2081989T3/es not_active Expired - Lifetime
- 1990-05-30 AU AU57492/90A patent/AU641166B2/en not_active Expired
- 1990-05-30 DK DK90909011.0T patent/DK0484340T3/da active
- 1990-05-30 JP JP2508553A patent/JP3012319B2/ja not_active Expired - Lifetime
- 1990-07-27 IE IE273790A patent/IE63053B1/en not_active IP Right Cessation
-
1992
- 1992-04-30 US US07/876,487 patent/US5306710A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH05501856A (ja) | 1993-04-08 |
DK0484340T3 (da) | 1996-04-22 |
CA2064039A1 (en) | 1991-01-29 |
DE69024053T2 (de) | 1996-07-04 |
EP0484340A1 (en) | 1992-05-13 |
AU641166B2 (en) | 1993-09-16 |
ES2081989T3 (es) | 1996-03-16 |
US5306710A (en) | 1994-04-26 |
AU5749290A (en) | 1991-03-11 |
JP3012319B2 (ja) | 2000-02-21 |
WO1991001997A1 (en) | 1991-02-21 |
US5137871A (en) | 1992-08-11 |
ATE131064T1 (de) | 1995-12-15 |
EP0484340B1 (en) | 1995-12-06 |
DE69024053D1 (de) | 1996-01-18 |
IE63053B1 (en) | 1995-03-22 |
EP0484340A4 (en) | 1993-02-17 |
IE902737A1 (en) | 1991-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2064039C (en) | Treatment to reduce edema for brain and musculature injuries | |
US4378347A (en) | Composition for treating the heart for myocardial infarction | |
US4296100A (en) | Method of treating the heart for myocardial infarction | |
US4801612A (en) | Method of inhibiting inflammatory response | |
JP2992855B2 (ja) | 潅流を増大させるための低投与量ヘモグロビンの投与 | |
US7799760B2 (en) | Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention | |
US8329641B2 (en) | Remedies for ischemic disease of the limbs comprising administration of G-CSF | |
KR100839857B1 (ko) | 동맥혈의 전달이상으로 인한 조직손상 치료용 약제학적조합 | |
US5177060A (en) | Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues | |
US5488033A (en) | Treatment to reduce edema | |
US5374621A (en) | Neurotensin method for inhibiting vascular leakage | |
Padbury et al. | Neonatal adaptation: naloxone increases the catecholamine surge at birth | |
US6060449A (en) | Neovascularization inhibitor containing tissue factor pathway inhibitor | |
RU2202362C2 (ru) | Композиция для местного применения, содержащая фактор роста эпидермиса человека | |
US10722557B2 (en) | Treatment of ischemia reperfusion injury using alpha-2 macroglobulin | |
JP2001514629A (ja) | 薬剤製造へのヒトα▲下1▼−酸性糖蛋白質の使用法 | |
US20030069174A1 (en) | Use of human alpha1-acid glycoprotein for producing a pharmaceutical preparation | |
SU1762932A1 (ru) | Способ профилактики острой сердечной недостаточности при операци х с искусственным кровообращением | |
CZ321699A3 (cs) | Použití humánního alfal-kyselého glykoproteinu k výrobě farmaceutického přípravku | |
YE et al. | Twenty-one cases of large area deep burn previously treated with dry therapy but not cured finally cured by MEBT | |
JPH03106822A (ja) | 皮膚創傷・皮膚疾患治療用注射剤 | |
JPS60156619A (ja) | 脳虚血治療用医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |